April 2019. Researchers say an experimental stroke drug prevented blood clots without the typical side effect of blood thinners: increased bleeding risk.
Media Coverage
April 18, 2019
New antiplatelet may lower bleeding risk in stroke
April 2019. The novel antiplatelet agent ACT017 confers reduced risk for bleeding in healthy volunteers and may be a safe and effective alternative for patients with stroke, according to early findings published in Arteriosclerosis, Thrombosis and Vascular Biology.
April 18, 2019
Experimental Blood Thinner May Help Prevent Stroke, Without the Bleeding Risk
April 2019. Researchers say an experimental stroke drug prevented blood clots without the typical side effect of blood thinners: increased bleeding risk.
April 18, 2019
New drug to prevent clots clears safety hurdle
April 2019. An experimental type of anti-clotting drug appears to be safe, according to an early-phase study.
April 18, 2019
Experimental Blood Thinner May Help Prevent Stroke, Without the Bleeding Risk
April 18, 2019. Researchers say an experimental stroke drug prevented blood clots without the typical side effect of blood thinners: increased bleeding risk.
April 18, 2019
Novel Antiplatelet May Offer Antithrombotic Effect Without Bleeding Risk
ACT017, a novel antiplatelet agent, has consistent pharmacokinetic and pharmacodynamic properties and appears to be safe and tolerable, according to results of a first-in-human, randomized, placebo-controlled phase 1 study.